Cargando…

Effects of Shugan Hewei Granule on Depressive Behavior and Protein Expression Related to Visceral Sensitivity in a Rat Model of Nonerosive Reflux Disease

OBJECTIVE: To explore the effect of Shugan Hewei Granule (SGHWG) and to provide the experimental basis for its clinical application. METHODS: 40 healthy male Wistar rats were divided into 5 groups, with 8 rats in each group, including control group, model group, normal saline (NS) group, SGHWG group...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yi, Li, Guanwu, Wang, Xiaosu, Zhu, Shengliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334618/ https://www.ncbi.nlm.nih.gov/pubmed/30719054 http://dx.doi.org/10.1155/2019/1505693

Ejemplares similares

Tandem Mass Tag Analysis of the Effect of the Anterior Cingulate Cortex in Nonerosive Reflux Disease Rats with Shugan Jiangni Hewei Granules Treatment
por: Wang, Tianzuo, et al.
Publicado: (2022)

Zhujie Hewei Granules Ameliorated Reflux Esophagitis in Rats
por: Qiu, Yue, et al.
Publicado: (2019)

Progress on the Mechanism of Visceral Hypersensitivity in Nonerosive Reflux Disease
por: Xu, Cao, et al.
Publicado: (2022)

Herbal Medicine Hewei Jiangni Decoction Is Noninferior to Oral Omeprazole for the Treatment of Nonerosive Gastroesophageal Reflux Disease: A Randomized, Double-Blind, and Double-Dummy Controlled Trail
por: Li, Feng, et al.
Publicado: (2022)

Nonerosive Reflux Disease (NERD) - An Update
por: Hershcovici, Tiberiu, et al.
Publicado: (2010)

Shugan Hewei Decoction Alleviates Cecum Mucosal Injury and Improves Depressive- and Anxiety-Like Behaviors in Chronic Stress Model Rats by Regulating Cecal Microbiota and Inhibiting NLRP3 Inflammasome
por: Yue, Yingying, et al.
Publicado: (2021)

Network Pharmacology Analysis of Hewei Jiangni Granule for Gastroesophageal Reflux Disease and Experimental Verification of Its Anti-Neurogenic Inflammation Mechanism
por: Cheng, Yuan, et al.
Publicado: (2022)

Current Advances in the Diagnosis and Treatment of Nonerosive Reflux Disease
por: Chen, Chien-Lin, et al.
Publicado: (2013)

Juice Test for Identification of Nonerosive Reflux Disease in Heartburn Patients
por: Fernandes, Michel R, et al.
Publicado: (2018)

Dynorphin participates in interaction between depression and non-erosive reflux disease
por: Wang, Yi, et al.
Publicado: (2022)

Shugan granule contributes to the improvement of depression‐like behaviors in chronic restraint stress‐stimulated rats by altering gut microbiota
por: Li, Junnan, et al.
Publicado: (2022)

Role of Saliva in Esophageal Defense: Implications in Patients With Nonerosive Reflux Disease
por: Yandrapu, Harathi, et al.
Publicado: (2015)

Antireflux surgery is equally beneficial in nonerosive and erosive gastroesophageal reflux disease
por: Park, Joong-Min, et al.
Publicado: (2018)

Correlation of Narrow Band Imaging Endoscopy and Histopathology in the Diagnosis of Nonerosive Reflux Disease
por: Arul, P, et al.
Publicado: (2015)

Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
por: Gold, Benjamin D., et al.
Publicado: (2017)

Washed microbiota transplantation reduces proton pump inhibitor dependency in nonerosive reflux disease
por: Zheng, Ya-Mei, et al.
Publicado: (2021)

Danshao Shugan Granule therapy for non-alcoholic fatty liver disease
por: Wang, Hui, et al.
Publicado: (2022)

Characteristics of Symptom Presentation and Risk Factors in Patients with Erosive Esophagitis and Nonerosive Reflux Disease
por: Lee, Shou-Wu, et al.
Publicado: (2014)

Multichannel impedance monitoring for distinguishing nonerosive reflux esophagitis with minor changes on endoscopy in children
por: Junko, Fujino, et al.
Publicado: (2021)

The relationship between esophageal acidity and symptom frequency in symptomatic nonerosive gastroesophageal reflux disease
por: Gardner, Jerry D.
Publicado: (2022)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up
por: He, Suyu, et al.
Publicado: (2020)

Chaihu-Shugan-San Administration Ameliorates Perimenopausal Anxiety and Depression in Rats
por: Chen, Shujiao, et al.
Publicado: (2013)

Efficacy and Safety of Traditional Chinese Medicine on Nonerosive Reflux Disease: A Meta-Analysis of Randomized Controlled Trials
por: Xiao, Jiao, et al.
Publicado: (2018)

Impact of Overlapping Functional Gastrointestinal Disorders on the Presentation and Quality of Life of Patients with Erosive Esophagitis and Nonerosive Reflux Disease
por: Lee, Shou-Wu, et al.
Publicado: (2015)

Effects of Chaihu-Shugan-San for reflux esophagitis: A protocol for systematic review and meta-analysis
por: Zhou, Yan, et al.
Publicado: (2020)

Nonerosive gastroesophageal reflux disease and mild degree of esophagitis: Comparison of symptoms endoscopic, manometric and pH-metric patterns
por: Grande, Michele, et al.
Publicado: (2012)

Outcomes in patients with nonerosive reflux disease treated with a proton pump inhibitor and alginic acid ± glycyrrhetinic acid and anthocyanosides
por: Di Pierro, Francesco, et al.
Publicado: (2013)

Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2019)

Identification of Unique Transcriptomic Signatures and Hub Genes Through RNA Sequencing and Integrated WGCNA and PPI Network Analysis in Nonerosive Reflux Disease
por: Zhao, Ye, et al.
Publicado: (2021)

Antidepressant-like effects of Chaihu-Shugan-San via SAPK/JNK signal transduction in rat models of depression
por: Li, Yun-Hui, et al.
Publicado: (2014)

On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis
por: Khan, Zubair, et al.
Publicado: (2018)

Efficacy and safety of Shugan Jieyu Decoction in the treatment of coronary heart disease complicated with depression
por: Li, Zhenzhen, et al.
Publicado: (2023)

Efficacy of Self-Made Hewei Decoction for Chronic Atrophic Gastritis and Its Effect on Gastrin and Pepsinogen Expression Levels
por: Ou, Jianyun, et al.
Publicado: (2022)

Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression
por: Qiu, Juan, et al.
Publicado: (2014)

Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2016)

Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial
por: Odaka, Takeo, et al.
Publicado: (2017)

The Usefulness of Esophageal Baseline Impedance Levels for the Diagnosis of Nonerosive Reflux Disease and the Proper Time for Measurement in Endoscopy-negative Korean Patients With Esophageal or Supraesophageal Symptoms
por: Kim, Young-Gun, et al.
Publicado: (2020)

Shugan Jieyu Capsule in Post-Stroke Depression Treatment: From Molecules to Systems
por: Zhang, Meng, et al.
Publicado: (2022)

Meta-analysis of Shugan Jieyu Capsule for depression in patients with coronary heart disease
por: Liu, Zhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l9ltqcv3qja304rmd2p5f6auco